Skip to main content
SearchLogin or Signup

Reviews of "Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis"

Reviewers: Hector Chinoy, Alexander Oldroyd (The University of Manchester) | 📒📒📒◻️◻️ • Cristiana Santos (Complejo Asistencial Universitario de Leon) | 📗📗📗📗◻️

Published onOct 08, 2020
Reviews of "Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis"

To read the original manuscript, click the link above.

Summary of Reviews: This potentially informative article with some methodological flaws suggests that glucocorticoids are associated with increased COVID-19 risk among patients with chronic inflammatory arthritis. Patients treated with Disease-Modifying Drugs (DMARDS) were at reduced risk.

Reviewer 1 (Hector Chinoy, Alexander Oldroyd) | 📒📒📒◻️◻️

Reviewer 2 (Cristiana Santos) | 📗📗📗📗◻️

RR:C19 Strength of Evidence Scale Key

📕 ◻️◻️◻️◻️ = Misleading

📙📙 ◻️◻️◻️ = Not Informative

📒📒📒 ◻️◻️ = Potentially Informative

📗📗📗📗◻️ = Reliable

📘📘📘📘📘 = Strong

To read the reviews, click the links below.

Comments
0
comment

No comments here